Biogen (BIIB) – Analyst EPS View
-
5 stocks to own and 5 stocks to avoid for Q2 earnings season as per Goldman Sachs
-
Biogen (BIIB) Poised to Address Early Alzheimer's Market From 2023 - Goldman Sachs
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BIIB Stock Lookup